Provectus Biopharmaceuticals, Inc. [PVCT]

Source: 

Company Overview

Provectus Biopharmaceuticals, Inc., a Delaware corporation incorporated in 2002 (together with its subsidiaries, Provectus or the Company), is a clinical-stage biotechnology company developing immunotherapy medicines for different diseases, based on a family of small molecules called halogenated xanthenes (HXs). Our lead HX molecule is named rose bengal sodium (RBS).